Condition: Aortic Stenosis · Sponsor: East and North Hertfordshire NHS Trust
This study aims to utilise novel biomarkers assessing thrombosis and thrombolysis (through a blood test), to identify patients undergoing either surgical aortic valve replacement (SAVR) or transcatheter aortic valve implantation (TAVI) who are at risk of thrombosis, and relate this to clinical thrombotic and thromboembolic adverse events and subclinical valve thrombosis, and identify the timeframe of greatest risk for valve thrombosis.
This description comes directly from the study's public registry record.
Diana A Gorog, MD,PhD,FRCP · 01707247512 · d.gorog@imperial.ac.uk
Rahim Kanji, MBBS,MRCP · 01438284753 · rahim.kanji04@imperial.ac.uk
Always discuss trial participation with your own doctor first.
| East and North Hertfordshire NHS Trust | Stevenage, Hertforshire, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04234841